Skip to content
10-Q

Quarterly Report

GROOVE BOTANICALS, INC. GRVE

0001171520-25-000038

← back to feed
Filed
Feb 25, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Feb 7, 2025 59.64M sh
Shares Diluted Q3 2025 · Dec 31, 2024 59.64M sh
Shares Diluted Q3 2025 · Dec 31, 2024 59.64M sh
Shares Diluted restated Q3 2025 · Dec 31, 2023 58.64M sh
Shares Diluted restated Q3 2025 · Dec 31, 2023 58.56M sh
Cash And Equivalents Q3 2025 · Dec 31, 2024 $1.25K
Cash And Equivalents Q3 2025 · Mar 31, 2024 $1.69K
Current Liabilities Q3 2025 · Dec 31, 2024 $1.03M
Current Liabilities Q3 2025 · Mar 31, 2024 $762.7K
Total Liabilities Q3 2025 · Dec 31, 2024 $1.03M
Total Liabilities Q3 2025 · Mar 31, 2024 $762.7K
Current Assets Q3 2025 · Dec 31, 2024 $4.73K
Current Assets Q3 2025 · Mar 31, 2024 $2.14K
Total Assets Q3 2025 · Dec 31, 2024 $4.73K
Total Assets Q3 2025 · Mar 31, 2024 $2.14K
Eps Basic Q3 2025 · Dec 31, 2024 $0.00
Eps Basic Q3 2025 · Dec 31, 2024 $0.00
Eps Basic Q3 2025 · Dec 31, 2023 $0.00
Eps Basic Q3 2025 · Dec 31, 2023 $0.00
Operating Cash Flow restated Q3 2025 · Dec 31, 2023 −$62.77K
Stockholders Equity restated Q3 2025 · Dec 31, 2023 −$646.33K
Stockholders Equity restated Q3 2025 · Sep 30, 2023 −$625.51K
Stockholders Equity restated Q3 2025 · Jun 30, 2023 −$540.84K
Stockholders Equity restated Q3 2025 · Mar 31, 2023 −$438.3K
Eps Diluted Q3 2025 · Dec 31, 2023 $0.00
Eps Diluted Q3 2025 · Dec 31, 2023 $0.00
Sga Expense restated Q3 2025 · Dec 31, 2023 $17.33K
Sga Expense restated Q3 2025 · Dec 31, 2023 $56.14K
Net Income restated Q3 2025 · Dec 31, 2023 $13.8K
Net Income restated Q3 2025 · Dec 31, 2023 −$142.48K
Operating Income restated Q3 2025 · Dec 31, 2023 −$55.2K
Operating Income restated Q3 2025 · Dec 31, 2023 −$206.97K